SoftwareOne, a leader in software solutions, finalized its acquisition of Crayon Group on July 2, 2025. Crayon shareholders are receiving cash and new SoftwareOne shares: 69 Norwegian kroner per share ...

What’s going on here? Australian shares might dip as new tariff threats from the US stir trade tensions with China, affecting supply chains. What does this mean? Renewed US tariff threats are ...

What’s going on here? TotalEnergies' plan to sell its North Sea assets to the Prax Group has hit a snag. Prax’s parent company is facing financial troubles, putting the deal in jeopardy. What does ...

What’s going on here? Federal Reserve Chair Jerome Powell has hit pause on interest rate cuts, citing high import tariffs and looming inflation even as jobs rise. What does this mean? Powell's ...

What’s going on here? Tesla shares dropped over 5% due to regulatory woes, while Ford's Q2 sales jumped 14%, boosting its market share to 14.3%. What does this mean? Tesla's facing a tough ride with ...

What’s going on here? Australia's carbon credit demand is expected to remain low until 2027, keeping prices steady around AU$40 per tonne. What does this mean? Australia's carbon credit market is ...

What’s going on here? Beijing Shougang LanzaTech Technology is set to captivate investors with its Hong Kong IPO, aiming to raise up to HK$380.6 million for carbon capture innovation. What does this ...

What’s going on here? Woolworths, Australia's largest supermarket chain, will close the MyDeal website by the end of September to curb financial losses amid strong competition. Closing MyDeal is ...

What’s going on here? The US and China struck a trade deal lifting rare earth export restrictions, yet Chinese markets responded with mixed results. What does this mean? The Shanghai Composite Index ...

The Daily Brief is a podcast that covers the top stories in finance each day – hit play to listen or follow the links below to read. Today's Stories SoftBank’s Going For AI And Cacti, With Plans To ...

The stock’s down 50%, but that doesn’t necessarily make it a steal. So Russell’s taken a closer look at the Danish pharma company behind Ozempic and Wegovy.

Economic woes and rising competition force Careem to suspend operations, spotlighting challenges for Pakistan's digital economy.